Dramatic Growth in Cancer Rates Predicted for Elderly, Minorities

Publication
Article
OncologyONCOLOGY Vol 23 No 6
Volume 23
Issue 6

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45%, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly (67% increase) and minority (100% increase) populations, according to research from The University of Texas M. D. Anderson Cancer Center.

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45%, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly (67% increase) and minority (100% increase) populations, according to research from The University of Texas M. D. Anderson Cancer Center. The study was based on statistics from the US Census Bureau and the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) registry.

Articles in this issue
Mate (Ilex paraguariensis)
Mate (Ilex paraguariensis)
Therapeutic Options in Relapsed or Refractory Diffuse Large B-cell Lymphoma: Part 1
Key Questions for Perioperative Chemotherapy in Resectable Lung Cancer
Adjuvant or Induction Cisplatin-Based Chemotherapy for Operable Lung Cancer
Adjuvant vs Neoadjuvant Chemotherapy in Resectable NSCLC: Is That the Real Question?
Pregnancy and Fertility With Breast Cancer: What Are the Options?
Breast Cancer in Women Under 40
Complexities of Adjuvant Endocrine Therapy in Young Premenopausal Women
Breast Cancer in Young Women: Clinical Decision-Making in the Face of Uncertainty
NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus
Dramatic Growth in Cancer Rates Predicted for Elderly, Minorities
Penn Study Examines Power of Exercise to Prevent Breast Cancer
The Pathway Ahead in Melanoma Trials
Treating Metastatic Melanoma: Further Considerations
Treatment of Metastatic Melanoma: An Overview
Treatment of Metastatic Melanoma: An Overview
Recent Videos
Related Content
Multiple Myeloma Experts Face Off on Sequencing Therapy Options

Multiple Myeloma Experts Face Off on Sequencing Therapy Options

ONCOLOGY Staff
November 21st 2024
Article

Experts in multiple myeloma gathered to debate current treatment options in the space during a recent Face Off.

Stem Cell Transplant Approaches for Patients With Blood Cancers

Stem Cell Transplant Approaches for Patients With Blood Cancers

David T. Scadden, MD
March 13th 2019
Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

Addressing Gaps in Education for Non–Clear Cell RCC

Addressing Gaps in Education for Non–Clear Cell RCC

ONCOLOGY Staff
November 19th 2024
Article

A panel discussed on RCC and the differentiation in the identification and treatment of clear and non-clear cell RCC.

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Geoffrey Y. Ku, MD
March 13th 2019
Podcast

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.

BTK Inhibitor Treatment Options Across the Lymphoma Landscape

BTK Inhibitor Treatment Options Across the Lymphoma Landscape

ONCOLOGY Staff
November 17th 2024
Article

Clinicians focused on CLL, follicular lymphoma, and MCL gathered during a Frontline Forum to discuss the use of BTKi in each respective disease state.

T-DXd Sequencing and Treatment Options in the Tumor-Agnostic Setting

T-DXd Sequencing and Treatment Options in the Tumor-Agnostic Setting

ONCOLOGY Staff
November 15th 2024
Article

HER-directed treatment approaches in the tumor-agnostic field were the highlight of the discussion for a panel of experts who convened at WCLC 2024.